Omthera Pharma Raises $6.5 Million
Omthera Pharmaceuticals Inc., a Bedminster, N.J.-based developer of dyslipidemia therapies, has raised $6.5 million in Series A funding led by Sofinnova Partners.
8 March 2010•4 mins read
Omthera Pharmaceuticals Inc., a Bedminster, N.J.-based developer of dyslipidemia therapies, has raised $6.5 million in Series A funding led by Sofinnova Partners.
